Publication Details

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
ATRA and anthracycline based therapy for acute myeloid leukaemia (AML). A guide for patients

ATRA and anthracycline based therapy for acute myeloid leukaemia (AML). A guide for patients (March 2018)

All-trans retinoic acid (ATRA), known as Tretinoin (Vesanoid®) is the acid form of vitamin A, which is used with chemotherapy for induction of remission in patients with confirmed acute promyelocytic leukaemia (APL), a subtype of acute myeloid leukaemia. This booklet describes the use of ATRA along with the chemotherapy drugs idarubicin and mitoxantrone.

Author(s)
Leukaemia Care
Place of publication
Worcester
Publisher
Date of publication
March 2018
Pages
20pp
Format
Booklet
Language
English
Flesch readability score
43.3
Download this resource
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm